| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.8M | -66.8% |
| SG&A Expense | $7.5M | -22.0% |
| Operating Income | -$19.3M | +60.1% |
| Pre-tax Income | -$16.2M | +67.2% |
| Income Tax | -$3.0M | -625.9% |
| Net Income | -$13.2M | +73.0% |
| EPS (Basic) | -$107.35 | -771.3% |
| EPS (Diluted) | -$107.35 | -771.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.6M | -90.8% |
| Total Assets | $1.6M | -91.1% |
| Current Liabilities | $3.1M | -40.6% |
| Total Liabilities | $3.5M | -67.8% |
| Stockholders' Equity | -$1.9M | -125.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.2M | +55.4% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$600K | -4094.6% |
| Financing Cash Flow | $4.3M | -3.2% |
| Free Cash Flow | -$18.2M | +55.4% |